AURKA and glioblastoma: We tested this hypothesis by measuring the sensitivity of glioblastoma stem cell enriched and more differentiated populations to MLN8237 and found that two independent GSC lines were indeed killed more efficiently by the AurA inhibitor (Fig. 4C).